Therapeutic dosing of busulfan helps reduce relapse in ASCTMarch 13, 2019TransplantationAggressive LymphomasLymphoma & Plasma Cell Disorders
Anti-CD45 conditioning looks safe, feasible in relapsed AMLMarch 13, 2019TransplantationAMLLeukemia, Myelodysplasia, Transplantation
HDACi, HMA combo improves survival for older AML patientsMarch 13, 2019AMLLeukemia, Myelodysplasia, Transplantation
Guadecitabine may be option for certain MDS/AML patientsMarch 12, 2019AMLLeukemia, Myelodysplasia, Transplantation
Myeloma risk score has treatment-planning potentialMarch 12, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Bendamustine-rituximab shines in frontline treatment of MCL, iNHLMarch 8, 2019Lymphoma & Plasma Cell Disorders
Engraftment achieved after conditioning without radiation, alkylating agentsMarch 7, 2019Transplantation
Post-HCT azithromycin doesn’t increase relapse risk, study suggestsMarch 3, 2019Leukemia, Myelodysplasia, TransplantationTransplantation
